Novel data-driven, equation-free method captures spatio-temporal patterns of neurodegeneration in Parkinson's disease: Application of dynamic mode decomposition to PET

by Jessie Fanglu Fu, Ivan S. Klyuzhin, Martin J. McKeown, A. Jon Stoessl, Vesna Sossi
Published 2020-01-01

The nature of progression in Parkinson's disease: an application of non-linear, multivariate, longitudinal random effects modelling.

by Lisa Kuramoto, Jacquelyn Cragg, Ramachandiran Nandhagopal, Edwin Mak, Vesna Sossi, Raul de la Fuente-Fernández, A Jon Stoessl, Michael Schulzer
Published 2013-01-01

Data-driven, voxel-based analysis of brain PET images: Application of PCA and LASSO methods to visualize and quantify patterns of neurodegeneration.

by Ivan S Klyuzhin, Jessie F Fu, Andy Hong, Matthew Sacheli, Nikolay Shenkov, Michele Matarazzo, Arman Rahmim, A Jon Stoessl, Vesna Sossi
Published 2018-01-01

Occult central pontine myelinolysis post liver transplant: A consequence of pre-transplant hyponatremia

by Julie Zhu, Fatema Al-Alkim, Trana Hussaini, Alexandra Vertinsky, Danielle Byrne, Siegfried R. Erb, A. Jon Stoessl, Eric M. Yoshida
Published 2019-07-01

Weeding through the haze: a survey on cannabis use among people living with Parkinson’s disease in the US

by Megan P. Feeney, Danny Bega, Benzi M. Kluger, A. Jon Stoessl, Christiana M. Evers, Rebeca De Leon, James C. Beck
Published 2021-03-01

Joint pattern analysis applied to PET DAT and VMAT2 imaging reveals new insights into Parkinson's disease induced presynaptic alterations

by Jessie Fanglu Fu, Ivan Klyuzhin, Jessamyn McKenzie, Nicole Neilson, Elham Shahinfard, Katie Dinelle, Martin J. McKeown, A. Jon Stoessl, Vesna Sossi
Published 2019-01-01

Investigation of serotonergic Parkinson's disease-related covariance pattern using [11C]-DASB/PET

by Jessie Fanglu Fu, Ivan Klyuzhin, Shuying Liu, Elham Shahinfard, Nasim Vafai, Jessamyn McKenzie, Nicole Neilson, Rostom Mabrouk, Matthew A. Sacheli, Daryl Wile, Martin J. McKeown, A. Jon Stoessl, Vesna Sossi
Published 2018-01-01

Neuroimaging biomarkers for clinical trials in atypical parkinsonian disorders: Proposal for a Neuroimaging Biomarker Utility System

by Thilo vanEimeren, Angelo Antonini, Daniela Berg, Nico Bohnen, Roberto Ceravolo, Alexander Drzezga, Günter U. Höglinger, Makoto Higuchi, Stephane Lehericy, Simon Lewis, Oury Monchi, Peter Nestor, Matej Ondrus, Nicola Pavese, María Cecilia Peralta, Paola Piccini, José Ángel Pineda‐Pardo, Irena Rektorová, María Rodríguez‐Oroz, Axel Rominger, Klaus Seppi, A. Jon Stoessl, Alessandro Tessitore, Stephane Thobois, Valtteri Kaasinen, Gregor Wenning, Hartwig R. Siebner, Antonio P. Strafella, James B. Rowe, MDS Neuroimaging Study Group and the JPND Working Group ASAP‐SynTau
Published 2019-12-01

Creation of an open-access, mutation-defined fibroblast resource for neurological disease research.

by Selina Wray, Matthew Self, NINDS Parkinson's Disease iPSC Consortium, NINDS Huntington's Disease iPSC Consortium, NINDS ALS iPSC Consortium, Patrick A Lewis, Jan-Willem Taanman, Natalie S Ryan, Colin J Mahoney, Yuying Liang, Michael J Devine, Una-Marie Sheerin, Henry Houlden, Huw R Morris, Daniel Healy, Jose-Felix Marti-Masso, Elisavet Preza, Suzanne Barker, Margaret Sutherland, Roderick A Corriveau, Michael D'Andrea, Anthony H V Schapira, Ryan J Uitti, Mark Guttman, Grzegorz Opala, Barbara Jasinska-Myga, Andreas Puschmann, Christer Nilsson, Alberto J Espay, Jaroslaw Slawek, Ludwig Gutmann, Bradley F Boeve, Kevin Boylan, A Jon Stoessl, Owen A Ross, Nicholas J Maragakis, Jay Van Gerpen, Melissa Gerstenhaber, Katrina Gwinn, Ted M Dawson, Ole Isacson, Karen S Marder, Lorraine N Clark, Serge E Przedborski, Steven Finkbeiner, Jeffrey D Rothstein, Zbigniew K Wszolek, Martin N Rossor, John Hardy
Published 2012-01-01